Consistent with our findings, the incidence of T2DM significantly increases among individuals with a family history of both hypertension and hypercholesterolemia, as well as with increased levels of inflammatory biomarkers, i.e., C-reactive protein and interleukin-6, as reported by others [28]. This evidence concerns the gene IL6 and Hypertension.